Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases

Autoimmunity

Volumn 41, Issue 8, 2008, Pages 639-647

  Marmont, Alberto M ^a   Burt, Richard ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

SLE; Stem cell transplantation

Indexed keywords

AZATHIOPRINE; CARMUSTINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; ENOXAPARIN; ETOPOSIDE; FONDAPARINUX; HYDROXYCHLOROQUINE; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; THIOTEPA; THYMOCYTE ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BULLOUS SKIN DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; GLOMERULONEPHRITIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MORTALITY; OUTCOME ASSESSMENT; PLASMAPHERESIS; PNEUMONIA; POLYARTHRITIS; REMISSION; STEM CELL MOBILIZATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SKIN DISEASES, VESICULOBULLOUS; YOUNG ADULT;

EID: 55149083679     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802198345     Document Type: Article

References (90)

1. Riemekasten, G. and Hahn, BH (2005) Key autoantigens in SLE. Rheumatology (Oxford), 44:8, pp. 975-982.
2. Matzinger, P. (1994) Tolerance, danger, and the extended family. Annu Rev Immunol, 12, pp. 991-1045.
3. Reines, BP (2001) Hypothesis. Bystanders or bad seeds? Many autoimmune-target cells may be transforming to cancer and signalling "danger" to the immune system. Autoimmunity, 33:2, pp. 121-134.
4. Diamond, B. et al. (1992) The role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol, 10, pp. 731-757.
5. Sciascia, SA et al. (2007) Immunization of nonautoimmune mice with DNA binding domains of the largest subunit of RNA polymerase I results in production of anti-dsDNA and anti-Sm/RNP antibodies. Autoimmunity, 40:1, pp. 38-47.
6. Goding, J. (2006) Advocatus diaboli: What is not known about autoimmune disease. The autoimmune diseases, pp. 1085-1093. Elsevier, Amsterdam/ Tokyo
7. Chiovato, L. et al. (2003) Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med, 139:5, pp. 346-351.
8. Feltkamp, T. (1999) The mystery of autoimmune diseases. The decade pf autoimmunity, pp. 1-5. Elsevier, Amsterdam/Tokyo
9. Liu, K. and Mohan, C. (2006) What do mouse models teach us about human SLE?. Clin Immunol, 119:2, pp. 123-130.
10. Sherer, Y. et al. (2004) Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum, 34:2, pp. 501-537.
11. Sherer, Y. and Shoenfeld, Y. (2007) Autoantibody explosion in lupus: 155 autoantibodies in SLE. Lupus, 16, p. 42.
12. Heissmeyer, V., Ansel, KM and Rao, A. (2005) A plague of autoantibodies. Nat Immunol, 6:7, pp. 642-644.
13. Block, SR (2006) A brief history of twins. Lupus, 15:2, pp. 61-64.
14. Cantor, RM et al. (2004) Systemic lupus erythematosus genome scan: Support for linkage at 1q23, 2q33, 16q12-13, and 17q21-23 and novel evidence at 3p24, 10q23-24, 13q32, and 18q22-23. Arthritis Rheum, 50:10, pp. 3203-3210.
15. Lipsky, PE (2001) Systemic lupus erythematosus: An autoimmune disease of B cell hyperactivity. Nat Immunol, 2:9, pp. 764-766.
16. Liossis, S-N and Tsokos, G. (2007) B-cells in human systemic lupus erythematosus. Systemic lupus erythematosus, pp. 103-108. Mosby/ Elsevier, St. Louis, MO/Amsterdam
17. Shim, YK et al. (2007) B cells behaving badly. Br J Haematol, 139:5, pp. 658-662.
18. Remmers, EF et al. (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med, 357:10, pp. 977-986.
19. Cervino, AC, Tsinoremas, NF and Hoffman, RW (2007) A genome-wide study of lupus: Preliminary analysis and data release. Ann N Y Acad Sci, 1110, pp. 131-139.
20. Ikehara, S. (2001) Treatment of autoimmune diseases by hematopoietic stem cell transplantation. Exp Hematol, 29:6, pp. 661-669.
21. van Bekkum, DW (2004) Stem cell transplantation for autoimmune disorders. Preclinical experiments. Best Pract Res Clin Haematol, 17:2, pp. 201-222.
22. Ikehara, S. (2008) Stem cell transplantation for autoimmune diseases: What can we learn from experimental models?. Autoimmunity
23. Smith-Berdan, S. et al. (2007) Reversal of autoimmune disease in lupus-prone New Zealand black/New Zealand white mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells. Blood, 110:4, pp. 1370-1378.
24. Marmont, AM (2004) Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications. Best Pract Res Clin Haematol, 17:2, pp. 223-232.
25. Sykes, M. and Nikolic, B. (2005) Treatment of severe autoimmune disease by stem-cell transplantation. Nature, 435:7042, pp. 620-627.
26. Marmont, AM (1993) Immune ablation with stem-cell rescue: A possible cure for systemic lupus erythematosus?. Lupus, 2:3, pp. 151-156.
27. Tyndall, A. and LeBlanc, K. (2006) Stem cells and rheumatology: Update on adult stem cell therapy in autoimmune diseases. Arthritis Rheum, 55:4, pp. 521-525.
28. Tyndall, A. and Saccardi, R. (2005) Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: Results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol, 141:1, pp. 1-9.
29. Burt, RK et al. (2002) Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure?. Blood, 99:3, pp. 768-784.
30. Muraro, PA and Douek, DC (2006) Renewing the T cell repertoire to arrest autoimmune aggression. Trends Immunol, 27:2, pp. 61-67.
31. de Kleer, I. et al. (2006) Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood, 107:4, pp. 1696-1702.
32. Hughes, G. (2007) Hughes syndrome: The growth of antiphospholipid syndrome. Lupus, 16, pp. 4-5.
33. Woolf, SH and George, JN (2000) Evidence-based medicine. Interpreting studies and setting policy. Hematol Oncol Clin North Am, 14:4, pp. 761-784.
34. Marmont, AM et al. (1997) Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus, 6:6, pp. 545-548.
35. Marmont, AM et al. (2006) Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34+) cell transplantation. Lupus, 15:1, pp. 44-46.
36. Burt, RK, Traynor, A. and Ramsey-Goldman, R. (1997) Hematopoietic stem-cell transplantation for systemic lupus erythematosus. N Engl J Med, 337:24, pp. 1777-1778.
37. Musso, M. et al. (1998) Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus, 7:7, pp. 492-494.
38. Fouillard, L. et al. (1999) Control of severe systemic lupus erythematosus after high-dose immunusuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood. Lupus, 8:4, pp. 320-323.
39. Trysberg, E., Lindgren, I. and Tarkowski, A. (2000) Autologous stem cell transplantation in a case of treatment resistant central nervous system lupus. Ann Rheum Dis, 59:3, pp. 236-238.
40. Rosen, O. et al. (2000) Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis Res, 2:4, pp. 327-336.
41. Lehnhardt, FG et al. (2006) Autologous blood stem cell transplantation in refractory systemic lupus erythematodes with recurrent longitudinal myelitis and cerebral infarction. Lupus, 15:4, pp. 240-243.
42. Brunner, M. et al. (2002) Autologous blood stem cell transplantation in refractory systemic lupus erythematosus with severe pulmonary impairment: A case report. Arthritis Rheum, 46:6, pp. 1580-1584.
43. Talaulikar, D. et al. (2005) Autologous peripheral blood stem cell transplantation with in vivo T-cell depletion for life threatening refractory systemic lupus erythematosus. Lupus, 14:2, pp. 159-163.
44. Elhasid, R. et al. (2004) Disappearance of diffuse calcinosis following autologous stem cell transplantation in a child with autoimmune disease. Bone Marrow Transplant, 33:12, pp. 1257-1259.
45. Jayne, D. et al. (2004) Autologous stem cell transplantation for systemic lupus erythematosus. Lupus, 13:3, pp. 168-176.
46. Burt, RK et al. (2006) Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA, 295:5, pp. 527-535.
47. Gharib, MI and Burnett, AK (2002) Chemotherapy-induced cardiotoxicity: Current practice and prospects of prophylaxis. Eur J Heart Fail, 4:3, pp. 235-242.
48. Saccardi, R. et al. (2004) Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis. Bone Marrow Transplant, 34:10, pp. 877-881.
49. Loh, Y. et al. (2007) Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: Feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remission. Bone Marrow Transplant, 40:1, pp. 47-53.
50. Traynor, AE et al. (2005) Prevalence and reversibility of pulmonary dysfunction in refractory systemic lupus: Improvement correlates with disease remission following hematopoietic stem cell transplantation. Chest, 127:5, pp. 1680-1689.
51. Ouyang, J. et al. (2001) [A pilot study in treatment of systemic lupus erythematosus by autologous bone marrow transplant]. Zhonghua Nei Ke Za Zhi, 40:4, pp. 229-231.
52. Zhao, X., Fu, Y. and Peng, X. (2002) Autologous hematopoietic stem cell transplantation in the treatment of systemic lupus erythematosus. Bone Marrow Transplant, 29, p. 5.
53. Lisukov, IA et al. (2004) High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus. Lupus, 13:2, pp. 89-94.
54. Kim, J., Hong, S. and Yoon, Sea (2005) Autologous stem cell transplantation using G-CSF primed bone marrow in severe refractory systemic lupus erythematosus. Bone Marrow Transplant, 35, p. 232.
55. Gualandi, F. et al. (2007) Autologous stem cell transplantation for severe autoimmune diseases: A 10-year experience. Ann N Y Acad Sci, 1110, pp. 455-464.
56. Gladman, DD et al. (2003) Clinically active serologically quiescent systemic lupus erythematosus. J Rheumatol, 30:9, pp. 1960-1962.
57. Alexander, T., Massenkeil, G. and Mei, Hea (2007) Normalisation of peripheral B cell abnormalities after immunoablation and autologous stem cell transplantation in refractory human lupus erythematosus. Lupus, 16, pp. 99-100.
58. Hoyer, BF et al. (2005) Long-lived plasma cells and their contribution to autoimmunity. Ann N Y Acad Sci, 1050, pp. 124-133.
59. Wilson, WA, Gharavi, AE and Piette, JC (2001) International classification criteria for antiphospholipid syndrome: Synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium. Lupus, 10:7, pp. 457-460.
60. Levine, JS, Branch, DW and Rauch, J. (2002) The antiphospholipid syndrome. N Engl J Med, 346:10, pp. 752-763.
61. Roubey, R. (2006) Antiphospholipid syndrome. The autoimmune diseases, pp. 381-399. Elsevier, Amsterdam/Tokyo
62. Khamastha, M. (2006) Hughes syndrome: Antiphospholipid syndrome. Springer Semin Immunopathol, London
63. Asherson, RA et al. (2003) Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines. Lupus, 12:7, pp. 530-534.
64. Shoenfeld, Y. (2003) Systemic antiphospholipid syndrome. Lupus, 12:7, pp. 497-498.
65. Hughes, G. (2007) Hughes syndrome: The growth of antiphospholipid syndrome. Lupus, 16, pp. 4-5.
66. Adachi, Y. et al. (1995) Effect of bone marrow transplantation on antiphospholipid antibody syndrome in murine lupus mice. Immunobiology, 192:34, pp. 218-230.
67. Hashimoto, N. et al. (2004) Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis. Bone Marrow Transplant, 33:8, pp. 863-866.
68. Statkute, L. et al. (2005) Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation. Blood, 106:8, pp. 2700-2709.
69. Gur-Lavi, M. (1999) Long-term remission with allogenic bone marrow transplantation in systemic lupus erythematosus. Arthritis Rheum, 42:8, p. 1777.
70. Khorshid, O. et al. (2004) Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus. J Rheumatol, 31:12, pp. 2513-2516.
71. Burt, RK et al. (2004) Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum, 50:8, pp. 2466-2470.
72. Pavletic, SZ (2004) Nonmyeloablative allogeneic hematopoietic stem cell transplantation for autoimmune disease. Arthritis Rheum, 50:8, pp. 2387-2390.
73. Olalla, JI et al. (1999) Disappearance of lupus anticoagulant after allogeneic bone marrow transplantation. Bone Marrow Transplant, 23:1, pp. 83-85.
74. Vanikar, AV et al. (2007) Hematopoietic stem cell transplantation in autoimmune diseases: The Ahmedabad experience. Transplant Proc, 39:3, pp. 703-708.
75. Li, N., Liu, Z., Hilario-Vargas, J. and Diaz, LA (2006) Bullous skin diseases: Pemphigus and pemphigoid. The autoimmune diseases, pp. 789-806. Elsevier, Amsterdam/Tokyo
76. Szabolcs, P. et al. (2002) Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease. Bone Marrow Transplant, 30:5, pp. 327-329.
77. Herr, AL et al. (2005) Successful anti-CD20 antibody treatment of pemphigus foliaceus after unrelated cord blood transplantation. Bone Marrow Transplant, 35:4, pp. 427-428.
78. Oyama, Y. et al. (2004) High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory pemphigus foliaceus. Bone Marrow Transplant, 34:12, pp. 1097-1098.
79. Brenner, MK (2004) Haematopoietic stem cell transplantation for autoimmune disease: Limits and future potential. Best Pract Res Clin Haematol, 17:2, pp. 359-374.
80. Burt, RK et al. (2006) Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: The evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum, 54:12, pp. 3750-3760.
81. Loh, Y. et al. (2007) Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: Role of conditioning regimen used. Blood, 109:6, pp. 2643-2648.
82. Isenberg, D. (2007) The use of B-cell depletion in the treatment of lupus. Lupus, 10, pp. 24-25.
83. Itoh, K. et al. (2006) Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus. Arthritis Rheum, 54:3, pp. 1020-1022.
84. Berger, JR and Koralnik, IJ (2005) Progressive multifocal leukoencephalopathy and natalizumab-unforeseen consequences. N Engl J Med, 353:4, pp. 414-416.
85. Furst, D. (2007) Autologous stem cell transplant (SCT) for SLE: Progress and competition. Lupus, 16, p. 70.
86. Mosca, M., Merrill, J. and Bombardieri, S. (2007) Assessment of disease activity in systemic lupus erythematosus. Systemic lupus erythematosus, pp. 19-23. Mosby/Elsevier, Philadelphia
87. Ramsey-Goodman, R. and Gladman, D. (2007) Disease development and outcome. Systemic lupus erythematosus, pp. 24-31. Mosby/Elsevier, Philadelphia
88. Petri, M., Jones, RJ and Brodsky, RA (2003) High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum, 48:1, pp. 166-173.
89. Brodsky, R. and Jones, R. (2008) Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: Advantages and disadvantages. Autoimmunity
90. Marmont, AM (2001) Lupus: Tinkering with haematopoietic stem cells. Lupus, 10:11, pp. 769-774.